Global Ethosuximide Market to Grow at a Healthy Pace During 2021-2026, Aided by the Rising Health Consciousness

North America is anticipated to be a key regional market for ethosuximide during the forecast period. The rise in the number of people affected by absence seizures is driving the ethosuximide industry. The increased usage of the drug by the pharmaceutical industry within India and China is contributing to the Asia Pacific market growth. The growing investments into the healthcare and pharmaceutical sectors to propel the market growth in the regions. The growing penetration and rising presence of the key players in the industry are further propelling the market growth in regions like the Asia Pacific. Major players like Pfizer are looking to expand their R&D capabilities in Asia, which is likely o aid the market growth in the coming years.

Ethosuximide has been listed as an essential medicine by the World Health Organization.  The rising health consciousness and product awareness among consumers is the key trend of the market. In 2020, Strides Pharma Science Ltd (NSE: STAR) announced that it had received approval for Ethoxusimide Softgel Capsules USP, 250mg from the United States Food & Drug Administration (USFDA). Thus, the rising approval of the product by various government organisations is expected to propel the growth of the market in the coming years.

Market Analysis by Form, Application, and Region:

• The market based on the form can be divided into capsules, tablets, and syrups.
• The major application segments for ethosuximide include hospitals and drug stores.
• The regional markets for ethosuximide include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• An increasing number of patients affected by seizures is driving the global market for ethosuximide.
• The growing health consciousness among consumers is further fuelling the market growth.
• Increasing investments in research and development are anticipated to provide an impetus for the growth of the ethosuximide industry.
• Rising disposable incomes and improved living standards are expected to aid the market growth further in the coming years.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for ethosuximide for the periods (2016-2020) and (2021-2026).
• The report also offers the historical (2016-2020) and forecast (2021-2026) markets for the forms, applications, and major regions of ethosuximide.
• It assesses the regional price trends for the (2016-2020) and (2021-2026) periods. 
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global ethosuximide market are Pfizer Inc., Akorn, Incorporated, and Chemwerth, Inc, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium-sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790